Clinical Trial

A Study to Prevent Infantile Spasms Relapse

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
After initially successful treatment, many children with infantile spasms unfortunately have a relapse, and relapse is linked to poor long-term outcomes such as autism and other forms of epilepsy. The aim of this study is to determine if treatment with low-dose prednisolone is safe, well tolerated, and effective in reducing the risk of relapse.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-02-04.
Status change: Not Yet Recruiting → Recruiting 2025-05-05
Trial Details
NCT Number NCT06819670
Lead Sponsor University of California, Los Angeles
Collaborators: Pediatric Epilepsy Research Foundation
Conditions Infantile Spasms, Infantile Epileptic Spasms Syndrome, West Syndrome
Enrollment 40 participants
Start Date 2025-05-05
Primary Completion 2028-02-28 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-08